Sabater Alfonso L

Simon Lilla, Murillo Brian A, Sabater Alfonso L

This review found diverse artificial tear compositions impact dry eye treatment; clinicians must tailor product selection to specific DED causes for optimal patient outcomes.

Mandell Jordan T, de Rivero Vaccari Juan Pablo, Sabater Alfonso L, Galor Anat

Inflammasomes are key in many ocular diseases, including glaucoma. Targeting this pathway offers promising new therapeutic strategies to reduce inflammation and disease progression.

Tovar Arianna, Gomez Angela, Serrano Andres, Blanco Maricarmen Perez, Galor Anat, Swaminathan Swarup S et al.

This study found elevated tear caspase-1 in ocular surface damage, correlating with clinical signs, suggesting its potential as a diagnostic biomarker and therapeutic target.

Naranjo Andrea, Pirakitikulr Nathan, Pelaez Daniel, Sabater Alfonso L, Monsalve Pedro, Amescua Guillermo et al.

This study linked retrocorneal membranes causing DSAEK failure, especially with glaucoma drainage devices, to myofibroblastic differentiation, suggesting endothelial origin and potential for targeted therapies.

Moreno-Montañés Javier, Martínez-de-la-Casa José M, Sabater Alfonso L, Morales-Fernandez Laura, Sáenz Cristina, Garcia-Feijoo Julián

This study compared Icare ONE (patient-used) and Icare PRO (clinician-used) rebound tonometers to Goldmann tonometry. Icare PRO was more accurate across IOP ranges, but Icare ONE shows promise for patient self-monitoring after training.